|
|
||||||||
Ann Thorac Surg 1983;36:187-192
© 1983 The Society of Thoracic Surgeons
Departments of Cardiology and Cardiovascular Surgery, Children's Hospital Medical Center, Boston, MA
Accepted for publication October 19, 1982.
* Address reprint requests to Dr. Levy, Department of Cardiology, Children's Hospital Medical Center, 300 Longwood Ave, Boston, MA 02115
Calcification of glutaraldehyde-preserved bioprosthetic cardiac valves represents a serious clinical problem. Previous work from this laboratory has established the presence in clinical bioprosthetic valve calcifications of vitamin K-dependent calcium-binding proteins, which contain the calcium-binding amino acid
-carboxyglutamic acid; no proteins containing
-carboxyglutamic acid are present in nonmineralized valves.
The purpose of the present study was to examine a series of bovine circulatory bioprosthetic valve explants for calcification and proteins containing
-carboxyglutamic acid. Biochemical analyses of explanted bioprosthetic valves from calves demonstrated proteins with
-carboxyglutamic acid accumulating in calcified valves during both the onset and progression of valve calcification; calcium levels in the explanted calf bioprostheses were in the same range as those noted in clinical material. Accumulation of calcium and protein with
-carboxyglutamic acid occurred simultaneously and progressively, beginning 2 months after implantation. Small amounts of osteocalcin, the bone-derived protein containing
-carboxyglutamic acid, were present in both human and bovine bioprosthetic valve calcifications at comparable levels. No osteocalcin was detectable in non-mineralized valve tissue. Warfarin anticoagulant therapy did not prevent calcification or accumulation of protein with
-carboxyglutamic acid. It is concluded that proteins containing
-carboxyglutamic acid are involved in both the onset and progression of bioprosthetic valve calcification, and that conventional means of vitamin K antagonism do not alter this association or the course of bioprosthetic valve mineralization.
This article has been cited by other articles:
![]() |
S. W. Chung, J. W. Kim, H. R. Lee, Y. D. Kim, and H. K. Chung Calcification of Experimental Valve Bioprostheses Asian Cardiovasc Thorac Ann, March 1, 2001; 9(1): 19 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Ilbawi, F. S. Idriss, S. Y. DeLeon, A. J. Muster, T. E. Berry, and M. H. Paul Long-Term Results of Porcine Valve Insertion for Pulmonary Regurgitation Following Repair of Tetralogy of Fallot Ann. Thorac. Surg., May 1, 1986; 41(5): 478 - 482. [Abstract] [PDF] |
||||
![]() |
R. Levy, J Wolfrum, F. Schoen, M. Hawley, S. Lund, and R Langer Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate Science, April 12, 1985; 228(4696): 190 - 192. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |